Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 6 open reading frame 118 (C6orf118) encodes an uncharacterized protein containing a translin-associated factor X-interacting N-terminus (TRAX) domain, which is involved in RNA binding and RNA nuclease activity, as well as the regulation of mitochondrial function and cellular homeostasis. The protein is predominantly localized to the mitochondria, cytosol, and nucleus, and is expressed at low to moderate levels across most tissues, with some higher expression in fetal brain, lung, trachea, salivary gland, and testis. Several isoforms exist, and its mRNA shows conserved regulatory elements. Disease associations include mitochondrial dysfunction, immune regulation, and variable expression in tuberculosis and immune cells. Direct therapeutic or drug targeting applications have not been established; its biological function is still under investigation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 6 open reading frame 118 (C6orf118).